| Imaging fibroblast activation protein alpha improves diagnosis of metastatic prostate cancer with positron emission tomography HM Hintz, JP Gallant, DJ Vander Griend, IM Coleman, PS Nelson, ... Clinical Cancer Research 26 (18), 4882-4891, 2020 | 55 | 2020 |
| The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates G Ye, J Gallant, J Zheng, C Massey, K Shi, W Tai, A Odle, M Vickers, ... Elife 10, e64815, 2021 | 46 | 2021 |
| Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography OC Ubah, EW Lake, GS Gunaratne, JP Gallant, M Fernie, AJ Robertson, ... Nature communications 12 (1), 7325, 2021 | 30 | 2021 |
| Exploitation of CD133 for the targeted imaging of lethal prostate cancer PM Glumac, JP Gallant, M Shapovalova, Y Li, P Murugan, S Gupta, ... Clinical Cancer Research 26 (5), 1054-1064, 2020 | 24 | 2020 |
| The development of a novel nanobody therapeutic for SARS-CoV-2 G Ye, JP Gallant, C Massey, K Shi, W Tai, J Zheng, AE Odle, MA Vickers, ... BioRxiv, 2020 | 20 | 2020 |
| The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase JP Gallant, RA Lima-Cordón, SA Justi, MC Monroy, T Viola, L Stevens Infection, Genetics and Evolution 62, 151-159, 2018 | 7 | 2018 |
| Unlocking Precision Gene Therapy: Harnessing AAV Tropism with Nanobody Swapping at Capsid Hotspots MD Hoffmann, JP Gallant, AM LeBeau, D Schmidt bioRxiv, 2024 | 2 | 2024 |
| Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein JP Gallant, HM Hintz, GS Gunaratne, MT Breneman, EE Recchia, JL West, ... Cancer Research Communications 4 (6), 1481-1494, 2024 | 1 | 2024 |
| Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer NY Luo, RL Minne, JP Gallant, GS Gunaratne, JL West, S Javeri, ... Bioconjugate Chemistry 35 (3), 389-399, 2024 | 1 | 2024 |
| FAP PET/CT imaging in radiation induced pulmonary fibrosis YM Guevara, C Massey, J Gallant, A Thickens, E Aluicio-Sarduy, J Engle, ... Journal of Nuclear Medicine 64 (supplement 1), P1536-P1536, 2023 | 1 | 2023 |
| Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl JP Gallant, D Hicks, K Shi, NH Moeller, B Hoppe, EW Lake, C Baehr, ... Journal of Biological Chemistry 300 (8), 2024 | | 2024 |
| Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity R Hernandez, A Lebeau, C Massey, Z Rosenkrans, J Gallant US Patent App. 18/332,457, 2023 | | 2023 |
| Developing Antibody and Nanobody Based Platforms Technologies for Targeting the Tumor Microenvironment JP Gallant University of Wisconsin--Madison, 2023 | | 2023 |
| ImmunoPET of fibroblast activation protein alpha detects disease activity of fibrotic interstitial lung disease R Hernandez, Z Rosenkrans, C Massey, J Gallant, A Thickens, K Bernau, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Detecting pulmonary fibrosis activity through immuno-PET imaging of fibroblast activation protein Z Rosenkrans, J Gallant, A Thickens, K Bernau, E Aluicio-Sarduy, ... Journal of Nuclear Medicine 63 (supplement 2), 2444-2444, 2022 | | 2022 |
| Natural selection and genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase J Gallant The University of Vermont and State Agricultural College, 2017 | | 2017 |
